Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages)
View the documentFOREWORD
View the documentACKNOWLEDGMENTS
View the documentINTRODUCTION
close this folderStandard Treatment Guidelines (STG)
Open this folder and view contents1. GASTROINTESTINAL CONDITIONS
close this folder2. RESPIRATORY DISEASES
close this folder2.1 Acute Respiratory Infections (ARI)
View the document2.1.1 Pneumonia
View the document2.1.2 ARI in Children
View the document2.1.3 Wheezing
View the document2.1.4 Croup
View the document2.1.5 Laryngeal Diphtheria
Open this folder and view contents2.1.6 ARI in Adult
View the document2.1.7 Chronic Bronchitis
View the document2.1.8 Other Respiratory Infections
close this folder2.1.9 Asthma
View the document2.1.9.1 Chronic Asthma in Adults
View the document2.1.9.2 Moderate Asthma in Adults
View the document2.1.9.3 Severe Asthma in Adults
View the document2.1.9.4 Maintenance therapy in children
View the document2.1.10 Cough
View the document2.1.11 Whooping Cough
View the document2.1.12 Allergic rhinitis
Open this folder and view contents3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION
Open this folder and view contents4. CARDIOVASCULAR DISEASES
Open this folder and view contents5. MALARIA
Open this folder and view contents6. SKIN DISEASES
Open this folder and view contents7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD)
Open this folder and view contents8. DENTAL AND ORAL CONDITIONS
Open this folder and view contents9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS
Open this folder and view contents10. EAR, NOSE AND THROAT CONDITIONS
Open this folder and view contents11. EYE CONDITIONS
Open this folder and view contents12. TUBERCULOSIS AND LEPROSY
Open this folder and view contents13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES
Open this folder and view contents14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS
Open this folder and view contents15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS
Open this folder and view contents16. OTHER DISEASE CONDITIONS
Open this folder and view contents17. VIRAL INFECTIONS
Open this folder and view contents18. ALLERGIC REACTIONS
Open this folder and view contents19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS
Open this folder and view contents20. MALIGNANT DISEASE CONDITIONS
Open this folder and view contents21. INJURIES AND TRAUMA
View the document22. FOREIGN BODIES
View the document23. PAIN
View the document24. POISONING
View the document25. NORMAL LABORATORY VALUES
Open this folder and view contentsNATIONAL ESSENTIAL DRUG LIST
View the documentABBREVIATIONS AND SYMBOLS
 
2.1.9.4 Maintenance therapy in children

Table: Asthma Maintenance therapy in Children

SEVERITY OF ASTHMA

TREATMENT

Mild Intermittent associate mainly with respiratory infections

Intermittent Treatment
Salbutamol (O) 0.15 mg/kg/day to the nearest 1 mg) in 2 to 4 divided doses
1 to 5 years: 1 to 2 mg four times a day
5 to 12 years: 2 to 4 mg four times a day
> 12 years: 4 mg four times a day
OR if available
Salbutamol inhaler intermittently

Moderate Frequent, triggered by infection, allergy, exercise etc.

Continuous Treatment
Salbutamol (O/Inhalation)as above
+/- Sodium cromoglycate Inhaler (if available) 1 mg (1 spincap) three to tour times a day. Dose may be increased to a maximum of 2 spincaps six times a day.

Severe Persistent, persistent wheeze and/or failure to

Add to the Above
Beclomethasone inhaler (50 micrograms/puff) 1 to 2 puffs three to four times a day respond to the above(always use a spacer)
OR
Prednisolone (O) 1 to 2 mg/kg/day initially, reducing to dose which controls the asthma; then attempt to give on alternative days (5 to 10 mg dose).

NOTE Long term prednisolone in children should be avoided unless there is no alternative.

Acute Attacks in Children

The same general measures apply as in adult. Give Several puffs of Salbutamol metered inhalation.

If poor response

Add

Adrenaline 1:1000 (SC) 0.01 ml/kg

OR

Aminophylline (slow IV) 4 mg/kg over 10 minutes. Do not give if oral aminophylline was given in the last 8 hours.

Unless response to the above is dramatic and complete, start:-

Prednisolone (O) 2 mg/kg/day in divided doses for 3-5 days. Severe

Acute Attack in children.

If response to the above therapy is inadequate, give

Dextrose 5% IV - 100 ml/kg/day

Plus

Aminophylline (IV infusion) at 0.8 - 1 mg/kg/hour

Plus

Hydrocortisone (IV) 2 mg/kg every 4 hours

Change to oral therapy when possible.

Prednisolone (O) 2 mg/kg/day for 5 days

Prophylaxis of asthma

Sodium cromoglycate is used in the prophylactic treatment of asthma including exercise-induced asthma. It should however, not be used for acute attacks of asthma as it has no effect on an established asthmatic attack. Sodium cromoglycate should be used regularly. When withdrawing treatment, the dose should be reduced gradually over a period of one week. Sodium cromoglycate should be used for at least 4 weeks before it can be proved as ineffective

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French